Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines-Reference-Cited by-同舟云学术

Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines

Published:2021-01-30 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Siddiqui Mariah,Shah Parth V,Balani Prachi,Lopez Angel R,Nobleza Chelsea Mae N,Khan Safeera

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference29 articles.

1. Migraine prevalence. A review of population-based studies;Stewart WF;Neurology,1994

2. Migraine: multiple processes, complex pathophysiology;Burstein R;J Neurosci,2015

3. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs;Kelman L;Headache,2004

4. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain;Noseda R;Pain,2013

5. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model;Bolay H;Nat Med,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic Review;F1000Research;2024-06-20

2. Long-Term Management of Migraine With OnabotulinumtoxinA (Botox) vs Calcitonin Gene-Related Peptide Antibodies (Anti-CGRP);Cureus;2023-10-08

3. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis;The Journal of Headache and Pain;2023-05-19

4. Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine;Current Medical Research and Opinion;2022-10-13

5. Management of chronic migraine;BMJ;2022-10-10